Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: The Lancet Infectious Diseases

Abbreviated Title: The Lancet Infectious Diseases

Publisher: Elsevier BV

ISSN (Print): 14733099

Publication date Created: December 2018

Publication date (Print): December 2018

Volume: 18

Issue: 12

Pages: 1319-1328

Article

DOI: 10.1016/S1473-3099(18)30554-1

PubMed ID: 30509675

SO-VID: d01ddebd-c1ab-46f4-a5fc-57c4275d8e8f

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.